drugset

drugset / Trial / NCT00564954

A Study of Dex-methylphenidate Extended Release in Children (6-12 Years) With Attention-Deficit/Hyperactivity Disorder (ADHD)

NCT00564954 ↗

Phase 4 Completed 86 enrolled Novartis Pharmaceuticals

RandomizedCrossoverTriple-blindTreatment

Summary

This study compared the efficacy of dex-methylphenidate extended release 20 mg versus placebo during an 8-hour laboratory classroom day.

Timeline

Start: 2007-10
Primary completion: 2007-11
Completion: 2007-11

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	dexmethylphenidate	Unknown	20 mg	Oral

Indications